跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
郭炤裕 Chao-Yu
教授
公共衛生研究所
電話
02-28267945
電子郵件
cyguo
nycu.edu
tw
網站
https://iph.ym.edu.tw/ezfiles/236/1236/img/1343/GuoCV-8-20-2021.pdf
h-index
h10-index
h5-index
4667
引文
34
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
821
引文
14
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
205
引文
10
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2003
2024
每年研究成果
概覽
指紋
網路
研究成果
(104)
類似的個人檔案
(6)
指紋
查看啟用 Chao-Yu Guo 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Framingham Heart Study
100%
Acute Heart Failure
79%
Taiwan
55%
Heart Failure with Preserved Ejection Fraction (HFpEF)
41%
Genome-wide Association Study
37%
Single nucleotide Polymorphism
34%
Clinical Outcomes
29%
Endometriosis
28%
Framingham Offspring Study
27%
Confidence Interval
26%
Epithelial Ovarian Cancer
26%
Hazard Ratio
25%
Common Genetic Variants
24%
Heart Failure
22%
Chronic Kidney Disease
22%
Odds Ratio
21%
All-cause Mortality
21%
Atrial Fibrillation
21%
Case-parent Trios
20%
Linkage Disequilibrium
20%
Uric Acid
19%
Logistic Regression
19%
Population-based Cohort Study
19%
Clinical Correlation
19%
Body Mass Index
19%
Linkage Analysis
18%
Multivariable
18%
Cardiovascular Risk
17%
Novel Machine
17%
Haplotype Relative Risk
17%
Genotype
17%
Mortality Risk
17%
Heritability
16%
Hospitalization
16%
Type I Error
16%
Quantitative Traits
16%
Randomized Controlled Trial
16%
SNP
16%
Patients with Heart Failure
16%
Blood Pressure
16%
Simulation Study
16%
Hypertension
15%
Left Ventricular Systolic Function
15%
Taiwanese
14%
Inflammatory Markers
14%
Inflammation
14%
Machine Learning Strategies
14%
C-reactive Protein
14%
Taiwanese Women
14%
National Cohort Study
14%
Medicine and Dentistry
Acute Decompensated Heart Failure
52%
Cohort Analysis
35%
Kidney Function
34%
Hazard Ratio
32%
Offspring
30%
Endometriosis
26%
Krukenberg Tumor
26%
Chronic Kidney Disease
25%
Congestive Heart Failure
25%
Blood Pressure
23%
Heart Failure with Reduced Ejection Fraction
22%
Biological Marker
21%
Body Mass Index
17%
All Cause Mortality
16%
Odds Ratio
16%
Systolic Function
15%
Systolic Blood Pressure
15%
Ejection Fraction
15%
Lung Function
14%
Cardiovascular Disease
14%
Heritability
13%
Quality of Life
13%
Nephropathy
13%
Open Angle Glaucoma
13%
QT Interval
13%
Forced Vital Capacity
12%
Interleukin 6
12%
Long Term Survival
12%
Cystatin C
11%
Diagnosis
11%
End Stage Renal Disease
11%
Cross Sectional Study
10%
Tumor Necrosis Factor
10%
Comorbidity
10%
Diseases
10%
Hemodynamic
9%
Heart Left Ventricle Ejection Fraction
9%
Cardiovascular Risk
9%
Chronic Obstructive Pulmonary Disease
9%
Breast Cancer
8%
Ankle Brachial Index
8%
Cancer
8%
Amino Terminal Sequence
8%
Maternal Age
8%
Proportional Hazards Model
8%
National Eye Institute Visual Function Questionnaire
8%
Logistic Regression Analysis
8%
Diastolic Blood Pressure
7%
Forced Expiratory Volume
7%
Endovascular Aneurysm Repair
7%